JONES WILLIAM A JR 4

What Happened William A. Jones Jr., a director of Apogee Therapeutics (APGE), was granted a derivative award on 2026-06-09 representing the right to purchase 7,657 shares of Apogee common stock. The grant shows $0.00 paid at acquisition (an option/award, not an immediate stock purchase).

Key Details

• Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (appears timely).
• Security: derivative option/award covering 7,657 shares; acquisition price reported as $0.00.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: The option vests on the one-year anniversary of the grant date, subject to the reporting person’s continued service to the company.
• Transaction type code: A (award/grant).

Context This was an option grant (not an exercise or sale). The award gives Jones the future right to buy shares if and when the option vests and is exercised; it does not represent immediate stock ownership or a sale. Such grants are common in compensation for directors and do not by themselves indicate the insider has bought or sold shares on the open market.